Investing.com - Novartis ADR reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Novartis ADR announced earnings per share of $1.66 on revenue of $12.96B. Analysts polled by Investing.com anticipated EPS of $1.54 on revenue of $12.59B.
Novartis ADR shares are down 4.44% from the beginning of the year and are trading at $90.24 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
Novartis ADR follows other major Healthcare sector earnings this month
Novartis ADR's report follows an earnings beat by Neogen on Tuesday, who reported EPS of $0.15 on revenue of $127.43M, compared to forecasts EPS of $0.1383 on revenue of $122.32M.
Kalvista Pharma had missed expectations on July 13 with first quarter EPS of $-0.65 on revenue of $0.00, compared to forecast for EPS of $-0.532 on revenue of $0.00.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar